POTS

Cardiac Autonomic Testing And Treating Heart Disease. “A Clinical Perspective” 2 Of 2

Articles /

Abstract Background Coronary heart disease (CHD) is a major health concern, affecting nearly half the middle-age population and responsible for nearly one-third of all deaths. Clinicians have several major responsibilities beyond diagnosing CHD, such as risk stratification of patients for major adverse cardiac events (MACE) and treating risks, as well as the patient. This second […]

Cardiac Autonomic Testing And Treating Heart Disease. “A Clinical Perspective” 2 Of 2 Read More »

Improved Patient Outcomes By Normalizing Sympathovagal Balance: Differentiating Syncope—Precise Subtype Differentiation Leads To Improved Outcomes

Articles /

Abstract Syncope is difficult to definitively diagnose, even with tilt-table testing and beat-to-beat blood pressure measurements, the gold-standard. Both are qualitative, subjective assessments. There are subtypes of syncope associated with autonomic conditions for which tilt-table testing is not useful. Heart rate variability analyses also include too much ambiguity. Three subtypes of syncope are differentiated: vasovagal

Improved Patient Outcomes By Normalizing Sympathovagal Balance: Differentiating Syncope—Precise Subtype Differentiation Leads To Improved Outcomes Read More »

Cardiac Autonomic Testing And Diagnosing Heart Disease. “A Clinical Perspective” 1 Of 2

Leave a Comment / Articles /

Abstract Background Coronary heart disease (CHD) is a major health concern, affecting nearly half the middle-age population and responsible for nearly one-third of all deaths. Clinicians have responsibilities beyond diagnosing CHD, including risk stratification of patients for major adverse cardiac events (MACE), modifying the risks and treating the patient. In this first of a two-part

Cardiac Autonomic Testing And Diagnosing Heart Disease. “A Clinical Perspective” 1 Of 2 Read More »

Clinical Autonomic Dysfunction

Leave a Comment / Articles /

PART 1: Introduction and History of Autonomic Nervous System Monitoring CHAPTER 1: Introduction to Parasympathetic and Sympathetic Monitoring This introductory section starts with a review of the “Old School” information commonly taught in medical school, including the anatomy of the autonomic nervous system (ANS) and its two branches, the parasympathetic and sympathetic nervous systems; the

Clinical Autonomic Dysfunction Read More »

PAGES

FORMS

RESOURCES

Sign Up For Our Newsletter

Physio PS © 2024 All Rights Reserved. The material and information provided by Physio PS is for general information purposes only. You should not rely upon this material or information for basis of making healthcare, treatment, or diagnosis decisions. While Physio PS strives to provide the most correct and up-to-date information and data, Physio PS makes no representations or warranties of any kind, expressed or implied, about the completeness, accuracy, reliability, suitability, or availability with respect to the information, products, services, or related graphics contained. Any reliance placed on such material is therefore strictly at your own risk. Reporting Information is supplied under license by NCRC LLC. * ‘RFa’ is known to be a measure of Parasympathetic activity and ‘LFa’ is known to be a measure of Sympathetic activity, based on reference: Colombo J, Arora RR, DePace NL, Vinik AI, Clinical Autonomic Dysfunction: Measurement, Indications, Therapies, and Outcomes. Springer Science + Business Media, New York, NY; 2014.

Scroll to Top

Become An Authorized Distributor